GSK has finally completed the sale of its stake in consumer health spin-off Haleon after selling another £1.3billion worth of shares.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.